{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nervous+System+Cancer&page=67",
    "query": {
      "condition": "Nervous System Cancer",
      "page": 67
    },
    "page_size": 10
  },
  "pagination": {
    "page": 67,
    "page_size": 10,
    "total_count": 3924,
    "total_pages": 393,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nervous+System+Cancer&page=68&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nervous+System+Cancer&page=66&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-11-21T21:46:28.595Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT00504660",
      "title": "6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Anaplastic Glioma of Brain",
        "Glioblastoma Multiforme",
        "Brain Cancer"
      ],
      "interventions": [
        {
          "name": "Capecitabine",
          "type": "DRUG"
        },
        {
          "name": "Celecoxib (Celebrex)",
          "type": "DRUG"
        },
        {
          "name": "Temozolomide",
          "type": "DRUG"
        },
        {
          "name": "Lomustine",
          "type": "DRUG"
        },
        {
          "name": "6-Thioguanine",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "12 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "12 Years and older"
      },
      "enrollment_count": 75,
      "start_date": "2003-09",
      "completion_date": "2010-08",
      "has_results": true,
      "last_update_posted_date": "2012-01-11",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Houston, Texas",
      "locations": [
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00504660"
    },
    {
      "nct_id": "NCT05230082",
      "title": "Acupuncture in Myasthenia Gravis (AcuMG)",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Myasthenia Gravis"
      ],
      "interventions": [
        {
          "name": "Acupuncture",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "HealthPartners Institute",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "80 Years",
        "sex": "ALL",
        "summary": "18 Years to 80 Years"
      },
      "enrollment_count": 24,
      "start_date": "2022-05-25",
      "completion_date": "2024-04-30",
      "has_results": true,
      "last_update_posted_date": "2025-09-18",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Saint Paul, Minnesota",
      "locations": [
        {
          "city": "Saint Paul",
          "state": "Minnesota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05230082"
    },
    {
      "nct_id": "NCT00704925",
      "title": "Treatment of Lambert-Eaton Syndrome With 3,4 DAP",
      "overall_status": "NO_LONGER_AVAILABLE",
      "study_type": "EXPANDED_ACCESS",
      "phases": [],
      "conditions": [
        "Lambert Eaton Myasthenic Syndrome"
      ],
      "interventions": [
        {
          "name": "3, 4 DAP",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "David P. Richman, MD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": null,
      "start_date": null,
      "completion_date": null,
      "has_results": false,
      "last_update_posted_date": "2019-10-30",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Sacramento, California",
      "locations": [
        {
          "city": "Sacramento",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00704925"
    },
    {
      "nct_id": "NCT00870779",
      "title": "Fluorescence Guided Resection of Brain Tumors",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Brain Tumors"
      ],
      "interventions": [
        {
          "name": "5-aminolevulinic acid",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "David W. Roberts",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "21 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "21 Years and older"
      },
      "enrollment_count": 105,
      "start_date": "2007-05",
      "completion_date": "2013-07-02",
      "has_results": false,
      "last_update_posted_date": "2019-06-14",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Lebanon, New Hampshire",
      "locations": [
        {
          "city": "Lebanon",
          "state": "New Hampshire"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00870779"
    },
    {
      "nct_id": "NCT01238250",
      "title": "Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "16P11.2 Deletion Syndrome",
        "16p11.2 Duplications",
        "1Q21.1 Deletion",
        "1Q21.1 Microduplication Syndrome (Disorder)",
        "ACTL6B",
        "ADNP",
        "AHDC1",
        "ANK2",
        "ANKRD11",
        "ARID1B",
        "ASH1L",
        "BCL11A",
        "CHAMP1",
        "CHD2",
        "CHD8",
        "CSNK2A1",
        "CTBP1",
        "CTNNB1 Gene Mutation",
        "CUL3",
        "DDX3X",
        "DNMT3A",
        "DSCAM",
        "DYRK1A",
        "FOXP1",
        "GRIN2A",
        "GRIN2B",
        "HIVEP2-Related Intellectual Disability",
        "HNRNPH2",
        "KATNAL2",
        "KDM5B",
        "KDM6B",
        "KMT2C Gene Mutation",
        "KMT2E",
        "KMT5B",
        "MBD5",
        "MED13L",
        "PACS1",
        "PPP2R5D-Related Intellectual Disability",
        "PTCHD1",
        "REST",
        "SCN2A Encephalopathy",
        "SETBP1 Gene Mutation",
        "SETD5",
        "SMARCA4 Gene Mutation",
        "SMARCC2",
        "STXBP1 Encephalopathy With Epilepsy",
        "SYNGAP1-Related Intellectual Disability",
        "TBR1",
        "ARHGEF9",
        "HNRNPU",
        "PPP3CA",
        "PPP2R1A",
        "SLC6A1",
        "2p16.3 Deletions",
        "5q35 Deletions",
        "5q35 Duplications",
        "7q11.23 Duplications",
        "15Q13.3 Deletion Syndrome",
        "16p11.2 Triplications",
        "16P12.2 Microdeletion",
        "16P13.11 Microdeletion Syndrome (Disorder)",
        "17Q12 Microdeletion Syndrome (Disorder)",
        "17Q12 Duplication Syndrome",
        "17Q21.31 Deletion Syndrome",
        "17q21.3 Duplications",
        "ACTB",
        "ADSL",
        "AFF2",
        "ALDH5A1",
        "ANK3",
        "ARX",
        "ATRX Gene Mutation",
        "AUTS2 Syndrome",
        "BCKDK",
        "BRSK2",
        "CACNA1C",
        "CAPRIN1",
        "CASK",
        "CASZ1",
        "CHD3",
        "CIC",
        "CNOT3",
        "CREBBP Gene Mutation",
        "CSDE1",
        "CTCF",
        "DEAF1",
        "DHCR7",
        "DLG4",
        "EBF3",
        "EHMT1",
        "EP300 Gene Mutation",
        "GIGYF1",
        "GRIN1",
        "GRIN2D",
        "IQSEC2-Related Syndromic Intellectual Disability",
        "IRF2BPL",
        "KANSL1",
        "KCNB1",
        "KDM3B",
        "NEXMIF",
        "KMT2A",
        "MBOAT7",
        "MEIS2",
        "MYT1L",
        "NAA15",
        "NBEA",
        "NCKAP1",
        "NIPBL",
        "NLGN2",
        "NLGN3",
        "NLGN4X",
        "NR4A2",
        "NRXN1",
        "NRXN2",
        "NSD1 Gene Mutation",
        "PHF21A",
        "PHF3",
        "PHIP",
        "PSMD12",
        "RELN",
        "RERE",
        "RFX3",
        "RIMS1",
        "RORB",
        "SCN1A",
        "SETD2 Gene Mutation",
        "SHANK2",
        "SIN3A",
        "SLC9A6",
        "SON",
        "SOX5",
        "SPAST",
        "SRCAP",
        "TAOK1",
        "TANC2",
        "TCF20",
        "TLK2",
        "TRIO",
        "TRIP12",
        "UPF3B",
        "USP9X",
        "VPS13B",
        "WAC",
        "WDFY3",
        "ZBTB20",
        "ZNF292",
        "ZNF462",
        "2Q37 Deletion Syndrome",
        "9q34 Duplications",
        "15q15 Deletions",
        "15Q24 Deletion",
        "NR3C2",
        "SYNCRIP",
        "2q37.3 Deletion",
        "6q16 Deletion",
        "15q11.2 BP1-BP2 Deletion",
        "16p13.3 Deletion",
        "17Q11.2 Microduplication Syndrome (Disorder)",
        "17p13.3",
        "Xq28 Duplication",
        "CLCN4",
        "CSNK2B",
        "DYNC1H1",
        "EIF3F",
        "GNB1",
        "MED13",
        "MEF2C",
        "RALGAPB",
        "SCN1B",
        "YY1",
        "Xp11.22 Duplication",
        "PACS2",
        "MAOA",
        "MAOB",
        "HNRNPC",
        "HNRNPD",
        "HNRNPK",
        "HNRNPR",
        "HNRNPUL2",
        "5P Deletion Syndrome",
        "TCF7L2 Gene Mutation",
        "HECW2",
        "PPM1D",
        "RNU4-2",
        "SNAP25",
        "FOXP2",
        "ITSN1"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Simons Searchlight",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 100000,
      "start_date": "2010-10",
      "completion_date": "2050-10",
      "has_results": false,
      "last_update_posted_date": "2026-07-23",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 2,
      "location_summary": "Boston, Massachusetts • Lewisburg, Pennsylvania",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Lewisburg",
          "state": "Pennsylvania"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01238250"
    },
    {
      "nct_id": "NCT02420613",
      "title": "Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Diffuse Intrinsic Pontine Glioma"
      ],
      "interventions": [
        {
          "name": "Radiation Therapy",
          "type": "RADIATION"
        },
        {
          "name": "Temsirolimus",
          "type": "DRUG"
        },
        {
          "name": "Vorinostat",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "RADIATION",
        "DRUG"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "7 Months",
        "maximum_age": "21 Years",
        "sex": "ALL",
        "summary": "7 Months to 21 Years"
      },
      "enrollment_count": 18,
      "start_date": "2015-10-05",
      "completion_date": "2025-03-28",
      "has_results": false,
      "last_update_posted_date": "2025-04-02",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Houston, Texas",
      "locations": [
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02420613"
    },
    {
      "nct_id": "NCT04369703",
      "title": "Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Sellar and Suprasellar Masses",
        "Pituitary Tumor"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Mayo Clinic",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "95 Years",
        "sex": "ALL",
        "summary": "18 Years to 95 Years"
      },
      "enrollment_count": 199,
      "start_date": "2020-01-28",
      "completion_date": "2022-04-29",
      "has_results": false,
      "last_update_posted_date": "2022-06-03",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Rochester, Minnesota",
      "locations": [
        {
          "city": "Rochester",
          "state": "Minnesota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04369703"
    },
    {
      "nct_id": "NCT02442297",
      "title": "T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Brain Tumor, Recurrent",
        "Brain Tumor, Refractory"
      ],
      "interventions": [
        {
          "name": "HER2-specific T cells",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Baylor College of Medicine",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "3 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "3 Years and older"
      },
      "enrollment_count": 10,
      "start_date": "2016-04-01",
      "completion_date": "2037-04",
      "has_results": false,
      "last_update_posted_date": "2026-09-15",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 2,
      "location_summary": "Houston, Texas",
      "locations": [
        {
          "city": "Houston",
          "state": "Texas"
        },
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02442297"
    },
    {
      "nct_id": "NCT01259479",
      "title": "Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumors",
        "Brain Tumors",
        "Brain Metastases"
      ],
      "interventions": [
        {
          "name": "Satraplatin",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "3 Years",
        "maximum_age": "25 Years",
        "sex": "ALL",
        "summary": "3 Years to 25 Years"
      },
      "enrollment_count": 9,
      "start_date": "2010-12-03",
      "completion_date": "2015-05-29",
      "has_results": false,
      "last_update_posted_date": "2018-07-05",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Bethesda, Maryland",
      "locations": [
        {
          "city": "Bethesda",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01259479"
    },
    {
      "nct_id": "NCT00001869",
      "title": "Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Leiomyomatosis"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 400,
      "start_date": "1998-12",
      "completion_date": "2003-04",
      "has_results": false,
      "last_update_posted_date": "2008-03-04",
      "last_synced_at": "2026-11-21T21:46:28.595Z",
      "location_count": 1,
      "location_summary": "Bethesda, Maryland",
      "locations": [
        {
          "city": "Bethesda",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00001869"
    }
  ]
}